|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-04-21 Purchase |
2009-04-23 5:28 pm | PHARMOS CORP | PARS.PK | Johnston Robert F (Executive Chairman Director) | 6,000,000 | $0.1 | $600,000 | 7,043,099 (Indirect) | View |
| 2009-04-21 Purchase | 2009-04-23 09:13 am |
PHARMOS CORP | PARS | EVNIN ANTHONY B (Director 10% owner) | 7,715,190 | $0 | $0 | 9,294,067 (Indirect) |
View |
| 2006-06-02 Purchase | 2006-06-02 12:38 pm | PHARMOS CORP | PARS | AVIV HAIM (Chairman and CEO Director) | 5,000 | $2.4 | $12,000 | 192,423 (Direct) | View |
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount | Shares Ownership | Filing |
| 2009-05-08 Other |
2009-05-12 6:44 pm |
PHARMOS CORP | PARS | NEW ENTERPRISE ASSOCIATES 10 L P NEA PARTNERS 10 L P BARRIS PETER J BARRETT M JAMES KRAMLICH C RICHARD PERRY MARK W SANDELL SCOTT D TRAINOR III EUGENE A (10% owner) | 543,427 | $0.054 | $29,345 | 14,435,105 (Direct) | View |
| 2009-05-08 Option Award | 2009-05-12 6:43 pm | PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director 10% owner) | 543,427 | $0.054 | $29,345 | 14,435,105 (Indirect) | View |
| 2009-05-08 Other |
2009-05-12 5:07 pm |
PHARMOS CORP | PARS | EVNIN ANTHONY B (Director 10% owner) | 370,432 | $0.054 | $20,003 | 9,664,499 (Indirect) |
View |
| 2009-05-08- -2009-05-11 Option Award Other | 2009-05-12 4:52 pm | PHARMOS CORP | PARS.PK | Johnston Robert F (Executive Chairman Director 10% owner) | 1,299,660 | $0.2073 | $269,382 | 12,057,949 (Indirect) |
View |
| 2009-04-21 Purchase |
2009-04-23 5:28 pm | PHARMOS CORP | PARS.PK | Johnston Robert F (Executive Chairman Director) | 3,715,190 | $0 | $0 | 10,758,289 (Direct) | View |
| 2009-04-21 Option Award |
2009-04-23 4:37 pm |
PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director 10% owner) | 11,636,364 | $0.1547 | $1,800,000 | 13,891,678 (Indirect) |
View |
| 2009-01-15 Option Award |
2009-01-16 2:28 pm |
PHARMOS CORP | PARS | Johnston Robert F (Executive Chairman Director) | 147,059 | $0.34 | $50,000 | 1,043,099 (Direct) | View |
| 2009-01-15 Option Award | 2009-01-16 1:49 pm |
PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director) | 147,059 | $0.34 | $50,000 | 2,176,488 (Indirect) |
View |
| 2008-08-05 Option Award(A) | 2008-08-13 5:43 pm | PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director) | 148,605 | $0.358 | $53,201 | 2,029,429 (Indirect) | View |
| 2008-08-05 Option Award | 2008-08-07 6:54 pm |
PHARMOS CORP | PARS | EVNIN ANTHONY B (Director) | 148,605 | $0.358 | $53,201 | 1,438,067 (Indirect) |
View |
| 2008-08-05 Other |
2008-08-06 2:23 pm | PHARMOS CORP | PARS | Johnston Robert F (Executive Chairman Director) | 148,605 | $0.358 | $53,201 | 148,605 (Direct) |
View |
| 2008-07-17 Option Award |
2008-07-18 10:14 am |
PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director) | 148,605 | $0.358 | $53,201 | 2,029,429 (Indirect) |
View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price | Shares Ownership | Filing |
| 2009-07-01 Option Award | 2009-07-06 4:48 pm | 2009-07-01 2019-06-30 | PHARMOS CORP | PARS | EVNIN ANTHONY B (Director) | 30,000 | $0.24 | 30,000 (Direct) |
View |
| 2009-07-01 Option Award |
2009-07-06 2:13 pm | 2009-07-01 2019-06-30 |
PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director) | 25,000 | $0.24 | 25,000 (Direct) |
View |
| 2009-07-01 Option Award | 2009-07-06 1:59 pm |
2009-07-01 2019-06-30 | PHARMOS CORP | PARS.PK | AKKARAJU SRINIVAS (Director) | 20,000 | $0.24 | 20,000 (Direct) | View |
| 2009-05-11 Option Award |
2009-05-13 5:55 pm | N/A 2019-05-10 | PHARMOS CORP | PARS.PK | AKKARAJU SRINIVAS (Director) | 100,000 | $0.22 | 100,000 (Direct) | View |
| 2009-05-11 Option Award | 2009-05-13 5:50 pm |
N/A 2019-05-10 |
PHARMOS CORP | PARS.PK | NEILL SYDNEY COLIN (President and CFO) | 600,000 | $0.22 | 600,000 (Direct) | View |
| 2009-04-21 Purchase | 2009-04-23 5:28 pm | 2009-04-21 2014-04-21 |
PHARMOS CORP | PARS.PK | Johnston Robert F (Executive Chairman Director) | 6,000,000 | $0.12 | 6,000,000 (Indirect) |
View |
| 2009-04-21 Purchase | 2009-04-23 5:28 pm | 2009-04-21 2012-11-01 | PHARMOS CORP | PARS.PK | Johnston Robert F (Executive Chairman Director) | 0 | $0 | 0 (Direct) |
View |
| 2009-04-21 Option Award |
2009-04-23 4:37 pm |
N/A 2014-04-21 | PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director 10% owner) | 8,000,000 | $0.12 | 8,000,000 (Indirect) |
View |
| 2009-04-21 Option Sale | 2009-04-23 4:37 pm |
N/A 2012-11-01 |
PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director 10% owner) | 0 | $0.275 | 0 (Indirect) | View |
| 2009-04-21 Purchase | 2009-04-23 09:13 am | 2009-04-21 2014-04-21 | PHARMOS CORP | PARS | EVNIN ANTHONY B (Director 10% owner) | 4,000,000 | $0.12 | 4,000,000 (Indirect) | View |
| 2008-01-03 Purchase | 2009-04-21 8:01 pm |
2008-11-01 2012-11-01 | PHARMOS CORP | PARS | EVNIN ANTHONY B (Director) | 180,000 | $0.275 | 180,000 (Indirect) | View |
| 2008-01-03 Purchase |
2009-04-21 8:01 pm | 2008-11-01 2012-11-01 |
PHARMOS CORP | PARS | EVNIN ANTHONY B (Director) | 800,000 | $0.275 | 800,000 (Indirect) |
View |
| 2008-01-03 Purchase | 2009-04-21 8:01 pm |
2008-11-01 2012-11-01 |
PHARMOS CORP | PARS | EVNIN ANTHONY B (Director) | 20,000 | $0.275 | 20,000 (Indirect) | View |
| 2009-01-15 Option Award | 2009-01-27 3:23 pm | 2009-01-15 2019-01-14 | PHARMOS CORP | PARS | AKKARAJU SRINIVAS (Director) | 20,000 | $0.14 | 20,000 (Direct) | View |
| 2009-01-15 Option Award | 2009-01-20 8:04 pm | 2009-01-15 2019-01-14 | PHARMOS CORP | PARS | EVNIN ANTHONY B (Director) | 22,500 | $0.14 | 22,500 (Direct) | View |
| 2009-01-15 Option Award |
2009-01-16 1:49 pm | 2009-01-15 2019-01-14 | PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director) | 22,500 | $0.14 | 22,500 (Direct) | View |
| 2008-07-01 Option Award |
2008-07-03 1:57 pm | 2008-07-01 2018-06-30 | PHARMOS CORP | PARS | MILLER LLOYD I III (Director) | 25,000 | $0.39 | 25,000 (Direct) |
View |
| 2008-01-23 Option Award | 2008-07-03 10:56 am |
2008-01-23 2018-01-22 | PHARMOS CORP | PARS | JP MORGAN PARTNERS BHCA LP JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P JPMP MASTER FUND MANAGER L P JPMP GLOBAL INVESTORS L P JPMP CAPITAL CORP (10% owner) | 20,000 | $0.35 | 20,000 (Indirect) | View |
| 2008-07-01 Option Award | 2008-07-03 10:28 am | 2008-07-01 2018-06-30 | PHARMOS CORP | PARS | JP MORGAN PARTNERS BHCA LP JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P JPMP MASTER FUND MANAGER L P JPMP GLOBAL INVESTORS L P JPMP CAPITAL LLC (10% owner) | 20,000 | $0.39 | 20,000 (Indirect) | View |
| 2008-07-01 Option Award | 2008-07-03 10:21 am | 2008-07-01 2018-06-30 |
PHARMOS CORP | PARS | AKKARAJU SRINIVAS (Director) | 20,000 | $0.39 | 20,000 (Indirect) | View |
| 2008-07-01 Option Award |
2008-07-02 8:02 pm |
2008-07-01 2018-06-30 |
PHARMOS CORP | PARS | NEWHALL CHARLES W III (Director) | 22,500 | $0.39 | 22,500 (Direct) | View |
| 2008-07-01 Option Award | 2008-07-02 6:58 pm |
2008-07-01 2018-06-30 |
PHARMOS CORP | PARS | EVNIN ANTHONY B (Director) | 22,500 | $0.39 | 22,500 (Direct) | View |
| 2008-07-01 Option Award |
2008-07-02 2:27 pm | 2008-07-01 2018-06-30 | PHARMOS CORP | PARS | GAMZU ELKAN R (Director) | 20,000 | $0.39 | 20,000 (Direct) |
View |
| 2007-01-17 Option Award | 2007-01-19 3:08 pm | N/A 2007-01-16 |
PHARMOS CORP | PARS | JP MORGAN PARTNERS BHCA LP (10% owner) | 20,000 | $1.84 | 20,000 (Indirect) |
View |
| 2007-01-17 Option Award | 2007-01-19 11:45 am |
N/A 2017-01-16 | PHARMOS CORP | PARS | SCHLACHET DAVID (Director) | 20,000 | $1.84 | 20,000 (Direct) | View |
| 2007-01-17 Option Award |
2007-01-19 11:38 am |
N/A 2017-01-16 |
PHARMOS CORP | PARS | Sartani Abraham (Director) | 20,000 | $1.84 | 20,000 (Direct) |
View |
| 2007-01-17 Option Award | 2007-01-19 11:10 am | N/A 2017-01-16 |
PHARMOS CORP | PARS | BEN DOR MONY (Director) | 20,000 | $1.84 | 20,000 (Direct) | View |
| 2007-01-17 Option Award |
2007-01-18 3:35 pm | N/A 2017-01-16 | PHARMOS CORP | PARS | Rubino Alan L (President and COO) | 50,000 | $1.84 | 50,000 (Direct) |
View |
| 2007-01-17 Option Award |
2007-01-18 3:17 pm | N/A 2017-01-16 |
PHARMOS CORP | PARS | AVIV HAIM (Chairman and CEO Director) | 60,000 | $1.84 | 60,000 (Direct) | View |
| 2006-01-25 Option Award |
2006-01-27 2:23 pm | N/A 2016-01-25 | PHARMOS CORP | PARS | MARSHALL LAWRENCE (Director) | 20,000 | $2.15 | 20,000 (Direct) | View |
| 2006-01-25 Option Award | 2006-01-27 1:46 pm | N/A 2016-01-25 | PHARMOS CORP | PARS | MARCEL GEORGES ANTHONY (Director) | 20,000 | $2.15 | 20,000 (Direct) | View |
| 2006-01-25 Option Award | 2006-01-27 1:28 pm |
N/A 2016-01-25 |
PHARMOS CORP | PARS | Meer James (Senior VP and CFO) | 25,000 | $2.15 | 25,000 (Direct) |
View |
| 2005-02-16 Option Award | 2005-02-22 2:04 pm | N/A 2015-02-16 |
PHARMOS CORP | PARS | RIESENFELD GAD (President and COO) | 135,000 | $0.77 | 135,000 (Direct) |
View |
| 2004-02-12 Option Award |
2004-02-24 3:11 pm |
N/A 2014-02-12 | PHARMOS CORP | PARS | COOK ROBERT W (Executive Vice President & CFO) | 115,000 | $4.24 | 115,000 (Direct) |
View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Fri, 20 Nov 2009 21:12:50 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |